Objectives: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a serious pathogen and its nasal carriage is a risk factor for subsequent infections. This study aims at determining the prevalence of and risk factors for CA-MRSA colonization at the time of hospital admission in our community. Methods: In one year period, patients coming to the emergency department of our hospital were interviewed and anterior nares cultures were obtained within 24 hours of admission. Antibiotic susceptibility tests were performed. A positive culture of MRSA within 24 hours of admission was considered as CA-MRSA. Chi-square test was performed for assessment of associations between culture results and the studied risk factors. Results: 56 (14%) and 11 (2.7%) of 400 patients had a nares culture positive for S. aureus and MRSA respectively. HIV infection (P value = 0.001), nursing homes residence (P value = 0.033) and nasal anatomic abnormalities (P value = 0.033) had significant association with CA-MRSA cultures. However in logistic regression, no statistically significant association was found. 45% of MRSA cultures showed induced resistance to clindamycin on D-test.
On tigacyline E-test, based on a 12 mg/ml cutoff for susceptibility, 6 (54.5%) showed resistance. Conclusion: Our study showed CA-MRSA prevalence to be 2.7% and didn't demonstrate any association between recent hospitalization, antibiotic use and intravenous drug abuse with CA-MRSA carriage unlike other studies. This may have been a result of CA-MRSA low prevalence.
OL-011 In vitro activity of fusidic acid against
Staphylococcus aureus strains , urine (n = 2), CVC (n = 1), traumas (n = 53), tracheal secretions (n = 1), body fluids (n = 9). Community strains mainly originated from trauma (n = 12), pus (n = 11), trachea fluid cultures (n = 3). None of the MSSA strains were found to be resistant to fusidic acid while 3/91 MRSA strains were resistant and 2/91 were intermediate. The resistance (R+I) of S. aureus strains to fusidic acid for outpatients and inpatients respectively were: 40% and 31% in 2008 to 44% and41% in 2010. The resistance (R+I) of MRSA for inpatients was 48.15%, for MSSA 8.3% and of MRSA for outpatients 75%. None of the outpatiens' strains MSSA showed resistance to fusidic acid. No strain of S. aureus showed resistance to vancomycin, daptomycin, teicoplanin and linezolid. Conclusions: Fusidic acid can be considered as an alternative drug for the treatment of infections due to both MRSA and MSSA strains. It has only a few side effects and is usually well-tolerated by patients as an oral drug. Methods: All isolates were determined for susceptibilities to common drugs using E-test method in accordance with manufacturers' guidelines, and broth microdilution method was used to check the results of macrolides-nonsuscepitible M. catarrhalis; Production of b-lactamase was performed by nitrocefin test; The method of PCR and sequence analysis was used to detect the presence of ermA, ermB, ermC, ermF , mefA, mefE genes and the presence of mutations in 23S rRNA gene among the 171 strains of M. catarrhalis (153
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